Amerise Biosciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 0.19 | TBA | TBA |
| Operating Expense | 0.08 | 0.02 | 0.03 |
| Net Profit | 0.11 | -0.02 | -0.03 |
| Net Profit Margin | 57.89 | TBA | TBA |
| Earning Per Share | 0.02 | TBA | -0.01 |
| EBIDTA | 0.11 | -0.02 | -0.03 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 0.19 |
| Operating Expense | 0.08 |
| Net Profit | 0.11 |
| Net Profit Margin | 57.89 |
| Earning Per Share | 0.02 |
| EBIDTA | 0.11 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | 9.01 |
| Operating Expenses Annual | 0.18 | 0.13 | 9.03 |
| Operating Profit Annual | -0.15 | -0.12 | 0.55 |
| Interest Annual | 0.00 | 0.00 | 0.00 |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | -0.15 | -0.12 | 0.55 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.18 |
| Operating Profit Annual | -0.15 |
| Interest Annual | 0.00 |
| Depreciation | TBA |
| Net Profit Annual | -0.15 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.01 | 0.01 | 0.02 |
| Cash Flow from Operations | -0.17 | -0.13 | 0.06 |
| Cash Flow from Investing | 0.27 | 0.13 | -0.15 |
| Cash Flow from Financing | -0.09 | 0.01 | 0.08 |
| Cash Flow at the End | 0.02 | 0.01 | 0.01 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.01 |
| Cash Flow from Operations | -0.17 |
| Cash Flow from Investing | 0.27 |
| Cash Flow from Financing | -0.09 |
| Cash Flow at the End | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -375 | -1,200 | 5.74 |
| PBIT Margin (%) | -375 | -1,200 | 5.74 |
| PBT Margin (%) | -375 | -1,200 | 5.74 |
| Net PROFIT Margin (%) | -375 | -1,200 | 5.74 |
| Return On Networth / Equity (%) | TBA | TBA | 9.34 |
| Return On Networth /Employed (%) | TBA | TBA | 9.27 |
| Return On Assets (%) | -3.75 | TBA | 10.16 |
| Total Debt / Equity (X) | 0.01 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 0.01 | TBA | 1.77 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -375 |
| PBIT Margin (%) | -375 |
| PBT Margin (%) | -375 |
| Net PROFIT Margin (%) | -375 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -3.75 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 0.02 | 0.01 | 6.23 |
| Non Current Assets Annual | 5.37 | 5.63 | 5.76 |
| Total Shareholders Funds Annual | 5.37 | 5.52 | 5.64 |
| Total Assets Annual | 5.39 | 5.65 | 11.99 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 0.02 |
| Non Current Assets Annual | 5.37 |
| Total Shareholders Funds Annual | 5.37 |
| Total Assets Annual | 5.39 |
No Data Availabe
